| Dr Leonard Christopher Treanor, MD | |
|
42388 Pelican Professional Park, Hammond, LA 70403-2412 | |
| (985) 542-6251 | |
| (985) 345-2386 |
| Full Name | Dr Leonard Christopher Treanor |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 19 Years |
| Location | 42388 Pelican Professional Park, Hammond, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487823506 | NPI | - | NPPES |
| 3810012786 | Medicaid | WV | |
| 000000255773 | Medicaid | OH | |
| 1091804 | Medicaid | LA | |
| 7100063680 | Medicaid | KY | |
| 2887630 | Medicaid | OH |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vital Link, A Home Care Company | Hammond, LA | Home health agency |
| Modern Home Health, Inc | Hammond, LA | Home health agency |
| Modern Hospice | Hammond, LA | Hospice |
| Lakeside Hospice, Llc | Metairie, LA | Hospice |
| Life Source Services Of Baton Rouge | Baton rouge, LA | Hospice |
| The Hospice Of Baton Rouge | Baton rouge, LA | Hospice |
| Hood Memorial Hospital | Amite, LA | Hospital |
| North Oaks Medical Center, L L C | Hammond, LA | Hospital |
| Cypress Pointe Surgical Hospital | Hammond, LA | Hospital |
| Belle Maison Nursing & Rehabilitation L L C | Hammond, LA | Nursing home |
| Trinity Neurologic Rehabilitation Center | Slidell, LA | Nursing home |
| Tangi Pines Nursing Center | Amite, LA | Nursing home |
| Heritage Healthcare - Hammond | Hammond, LA | Nursing home |
| Landmark Nursing Center Hammond | Hammond, LA | Nursing home |
| Entity Name | Internal Medicine Clinic Of Tangipahoa, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588678494 PECOS PAC ID: 9234034778 Enrollment ID: O20031206000015 |
News Archive
The results of a major clinical study carried out at the Montreal Heart Institute by Dr. Jean-Claude Tardif are now available in the journal Circulation Cardiovascular Imaging. Dr. Tardif is a cardiologist and director of the MHI Research Centre, as well as a professor in the faculty of medicine and holder of the atherosclerosis research chair at the Universit- de Montr-al.
Bristol-Myers Squibb Company and Pfizer announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for ELIQUIS (apixaban) for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, will be presenting new preclinical data in an animal model of Type 2 diabetes in which its anti-inflammatory therapeutic antibody candidate, XOMA 052, was used as monotherapy and in combination with the marketed anti-diabetic drugs exendin-4 (Byetta) or sitagliptin (Januvia).
Cantor Insurance Group, a unit of Cantor Fitzgerald LP, has joined with Healthcare Interactive to introduce Cantor Health Interactive, a new healthcare software management tool to help businesses monitor and reduce their healthcare costs.
A preprint discusses the results of a study of antibody responses to the first and second dose of currently available SARS-CoV-2 vaccines, Pfizer and Oxford.
› Verified 6 days ago
| Entity Name | Advanced Care Hospitalists Pl |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457389587 PECOS PAC ID: 5092753632 Enrollment ID: O20170206000606 |
News Archive
The results of a major clinical study carried out at the Montreal Heart Institute by Dr. Jean-Claude Tardif are now available in the journal Circulation Cardiovascular Imaging. Dr. Tardif is a cardiologist and director of the MHI Research Centre, as well as a professor in the faculty of medicine and holder of the atherosclerosis research chair at the Universit- de Montr-al.
Bristol-Myers Squibb Company and Pfizer announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for ELIQUIS (apixaban) for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, will be presenting new preclinical data in an animal model of Type 2 diabetes in which its anti-inflammatory therapeutic antibody candidate, XOMA 052, was used as monotherapy and in combination with the marketed anti-diabetic drugs exendin-4 (Byetta) or sitagliptin (Januvia).
Cantor Insurance Group, a unit of Cantor Fitzgerald LP, has joined with Healthcare Interactive to introduce Cantor Health Interactive, a new healthcare software management tool to help businesses monitor and reduce their healthcare costs.
A preprint discusses the results of a study of antibody responses to the first and second dose of currently available SARS-CoV-2 vaccines, Pfizer and Oxford.
› Verified 6 days ago
| Entity Name | Louisiana Hyperbarics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487002150 PECOS PAC ID: 9830472182 Enrollment ID: O20170210000877 |
News Archive
The results of a major clinical study carried out at the Montreal Heart Institute by Dr. Jean-Claude Tardif are now available in the journal Circulation Cardiovascular Imaging. Dr. Tardif is a cardiologist and director of the MHI Research Centre, as well as a professor in the faculty of medicine and holder of the atherosclerosis research chair at the Universit- de Montr-al.
Bristol-Myers Squibb Company and Pfizer announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for ELIQUIS (apixaban) for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, will be presenting new preclinical data in an animal model of Type 2 diabetes in which its anti-inflammatory therapeutic antibody candidate, XOMA 052, was used as monotherapy and in combination with the marketed anti-diabetic drugs exendin-4 (Byetta) or sitagliptin (Januvia).
Cantor Insurance Group, a unit of Cantor Fitzgerald LP, has joined with Healthcare Interactive to introduce Cantor Health Interactive, a new healthcare software management tool to help businesses monitor and reduce their healthcare costs.
A preprint discusses the results of a study of antibody responses to the first and second dose of currently available SARS-CoV-2 vaccines, Pfizer and Oxford.
› Verified 6 days ago
| Entity Name | Universal Behavioral Health Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1467019000 PECOS PAC ID: 8426387978 Enrollment ID: O20210928001006 |
News Archive
The results of a major clinical study carried out at the Montreal Heart Institute by Dr. Jean-Claude Tardif are now available in the journal Circulation Cardiovascular Imaging. Dr. Tardif is a cardiologist and director of the MHI Research Centre, as well as a professor in the faculty of medicine and holder of the atherosclerosis research chair at the Universit- de Montr-al.
Bristol-Myers Squibb Company and Pfizer announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for ELIQUIS (apixaban) for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, will be presenting new preclinical data in an animal model of Type 2 diabetes in which its anti-inflammatory therapeutic antibody candidate, XOMA 052, was used as monotherapy and in combination with the marketed anti-diabetic drugs exendin-4 (Byetta) or sitagliptin (Januvia).
Cantor Insurance Group, a unit of Cantor Fitzgerald LP, has joined with Healthcare Interactive to introduce Cantor Health Interactive, a new healthcare software management tool to help businesses monitor and reduce their healthcare costs.
A preprint discusses the results of a study of antibody responses to the first and second dose of currently available SARS-CoV-2 vaccines, Pfizer and Oxford.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Leonard Christopher Treanor, MD Po Box 1799, Hammond, LA 70404-1799 Ph: (985) 542-6251 | Dr Leonard Christopher Treanor, MD 42388 Pelican Professional Park, Hammond, LA 70403-2412 Ph: (985) 542-6251 |
News Archive
The results of a major clinical study carried out at the Montreal Heart Institute by Dr. Jean-Claude Tardif are now available in the journal Circulation Cardiovascular Imaging. Dr. Tardif is a cardiologist and director of the MHI Research Centre, as well as a professor in the faculty of medicine and holder of the atherosclerosis research chair at the Universit- de Montr-al.
Bristol-Myers Squibb Company and Pfizer announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for ELIQUIS (apixaban) for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, will be presenting new preclinical data in an animal model of Type 2 diabetes in which its anti-inflammatory therapeutic antibody candidate, XOMA 052, was used as monotherapy and in combination with the marketed anti-diabetic drugs exendin-4 (Byetta) or sitagliptin (Januvia).
Cantor Insurance Group, a unit of Cantor Fitzgerald LP, has joined with Healthcare Interactive to introduce Cantor Health Interactive, a new healthcare software management tool to help businesses monitor and reduce their healthcare costs.
A preprint discusses the results of a study of antibody responses to the first and second dose of currently available SARS-CoV-2 vaccines, Pfizer and Oxford.
› Verified 6 days ago
Edmund Ogden Spiller, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1902 S Morrison Blvd, Hammond, LA 70403 Phone: 985-230-5800 Fax: 985-230-5859 | |
Mark Stephen Daunis, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1900 S Morrison Blvd, Walk-in Clinic, Hammond, LA 70403 Phone: 985-230-5726 Fax: 985-230-5683 | |
Nathan Hensler, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 42078 Veterans Ave Ste B, Hammond, LA 70403 Phone: 985-490-3070 Fax: 985-490-3082 | |
Dr. Ryan Rhodes, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15813 Paul Vega Md Dr Ste 201, Hammond, LA 70403 Phone: 985-230-7440 Fax: 985-230-7441 | |
Michael Allen Drapcho, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1902 S Morrison Blvd, Hammond, LA 70403 Phone: 985-230-5800 Fax: 985-230-5859 | |
Dr. Michael Dunn, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 41676 Veterans Ave, Hammond, LA 70403 Phone: 985-543-3600 | |
Hugo Arturo Valdes, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1902 S Morrison Blvd, Hammond, LA 70403 Phone: 985-230-5800 Fax: 985-230-5859 |